Literature DB >> 24871977

Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B.

Zhi-Wei Song1, Yan-Xiu Ma, Bao-qing Fu, Xu Teng, Si-Jia Chen, Wei-Zhen Xu, Hong-Xi Gu.   

Abstract

To explore the relationship of the MOV10, A3G, and IFN-α mRNA levels with chronic hepatitis B virus (HBV) infection, Blood samples from 96 patients with chronic hepatitis B (CHB) and 21 healthy individuals as control were collected. HBV DNA load and aminotransferase in the serum were tested using real time PCR and velocity methods, respectively. The MOV10, A3G, and IFN-α mRNA levels in the peripheral blood mononuclear cells (PBMC) were examined through qRT-PCR. The MOV10, A3G, and IFN-α mRNA levels in CHB group was significantly lower than those in the control group (P<0.01, P<0.05, P<0.01, respectively). The A3G mRNA level in the high-HBV DNA load group was lower than that in the low-HBV DNA load group (P<0.05). However, no statistical difference was found in the MOV10 and IFN-α mRNA levels between the two HBV DNA load groups. Furthermore, the MOV10 mRNA level showed positive correlation with IFN-α in the control group. These results indicated that the expression of the innate immune factors MOV10, A3G, and IFN-α is affected by chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871977     DOI: 10.1007/s12275-014-3467-8

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  19 in total

1.  Chronic fatigue syndrome and immune dysfunction: cause or effect?

Authors:  Shimon Pollack
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

2.  The potential role of APOBEC3G in limiting replication of hepatitis B virus.

Authors:  Ashraf Mohamadkhani; Akbar Pourdadash; Sirous Tayebi; Arezoo Estakhri; Habibollah Nazem; Masoud Sotoudeh; Hossein Poustchi
Journal:  Arab J Gastroenterol       Date:  2013-01-08       Impact factor: 2.076

3.  Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.

Authors:  C L Lu; S T Tsai; C Y Chan; S J Hwang; C Y Tsai; J C Wu; R H Lu; B C Lin; S D Lee
Journal:  J Gastroenterol Hepatol       Date:  1997-04       Impact factor: 4.029

4.  Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.

Authors:  A Olivero; A Ciancio; M L Abate; S Gaia; A Smedile; M Rizzetto
Journal:  J Viral Hepat       Date:  2006-06       Impact factor: 3.728

5.  Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

Authors:  Vyacheslav Furtak; Alok Mulky; Stephen A Rawlings; Lina Kozhaya; KyeongEun Lee; Vineet N Kewalramani; Derya Unutmaz
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.

Authors:  Jean-Pierre Vartanian; Michel Henry; Agnès Marchio; Rodolphe Suspène; Marie-Ming Aynaud; Denise Guétard; Minerva Cervantes-Gonzalez; Carlo Battiston; Vincenzo Mazzaferro; Pascal Pineau; Anne Dejean; Simon Wain-Hobson
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

7.  Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

Authors:  Antonio Bertoletti; Carlo Ferrari
Journal:  Postgrad Med J       Date:  2013-05       Impact factor: 2.401

Review 8.  Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.

Authors:  Marianne Bonvin; Jobst Greeve
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

9.  G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection.

Authors:  Chiemi Noguchi; Michio Imamura; Masataka Tsuge; Nobuhiko Hiraga; Nami Mori; Daiki Miki; Takashi Kimura; Shoichi Takahashi; Yoshifumi Fujimoto; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Chise Tateno; Katsutoshi Yoshizato; Kazuaki Chayama
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

10.  Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.

Authors:  Michel Henry; Denise Guétard; Rodolphe Suspène; Christophe Rusniok; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

View more
  5 in total

1.  Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.

Authors:  Junsong Zhang; Feng Huang; Likai Tan; Chuan Bai; Bing Chen; Jun Liu; Juanran Liang; Chao Liu; Shaoying Zhang; Gen Lu; Yuan Chen; Hui Zhang
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 2.  Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma.

Authors:  Tomoyuki Honda; Md Arifur Rahman
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

3.  Evolutionary and Expression Analysis of MOV10 and MOV10L1 Reveals Their Origin, Duplication and Divergence.

Authors:  Shuaiqi Yang; Xiangmin Zhang; Xianpeng Li; Xiu Yin; Lei Teng; Guangdong Ji; Hongyan Li
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

Review 4.  Unwinding the roles of RNA helicase MOV10.

Authors:  Aatiqa Nawaz; Temirlan Shilikbay; Geena Skariah; Stephanie Ceman
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-07-29       Impact factor: 9.349

Review 5.  Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.

Authors:  Yuan Zhang; Xiaorong Chen; Yajuan Cao; Zongguo Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.